aking Good Measure: Valentina Moreno, Argentina: Diabetes Patient

Providing a Link Between Symptoms and Diagnosi: Dr. Martin Kroll, U.S.: Diagnostics User

Smiling at a Healthier Tomorrow: Amanda Graciola, Brazil: Pancreatic Disease Patient

Toward a Healthier Tomorrowl: Akira Kitamoto, Japan: Drug-eluting Stent User

Looking Toward a Brighter Future: Art Gilford, U.S.: Vision Disorder Patient

Moving Toward a Healthier Future: Ramy Radwan, U.S. : Crohn's Disease Patient

Helping Balance Her Body: Dr. Madhuri Kulkarni, India: Thyroid Patient

Finding the Right Match: Lenka Ruzickova, Czech Republic: Transplant Patient

Helping the Healing Process: LSegey Knyazitenkov, Russia: Adult Nutritionals User

News

Features

	Abbott Recognized as a Leading Employer Around the World Abbott prides itself on being a company that provides employees around the world opportunities to make a difference and advance their careers.
	Market-Leading XIENCE is Prime Example of Abbott Innovation Abbott's XIENCE family of drug eluting stents (which includes XIENCE V®, XIENCE PRIME™ and XIENCE nano™) is the worldwide drug eluting stent market leader for the treatment of coronary artery disease.
	Abbott's Longford, Ireland, Facility Celebrates Delivery of One-Billionth Test Abbott's Longford, Ireland, facility has been manufacturing medical diagnostic tests for global markets since 2005.